Navigation Links
Angiotech announces exclusive distribution agreement with B. Braun for Angiotech's proprietary Quill(TM) SRS product line
Date:5/3/2010

personnel; our ability to successfully complete pre-clinical and clinical development of our products; changes in our business strategy or development plans; our failure to obtain patent protection for discoveries; loss of patent protection resulting from third-party challenges to our patents; commercialization limitations imposed by patents owned or controlled by third parties; our ability to obtain rights to technology from licensors; liability for patent claims and other claims asserted against us; our ability to obtain and enforce timely patent and other intellectual property protection for our technology and products; the ability to enter into, and to maintain, corporate alliances relating to the development and commercialization of our technology and products; market acceptance of our technology and products; our ability to successfully manufacture, market and sell our products; the availability of capital to finance our activities; our ability to restructure and to service our debt obligations; and any other factors referenced in our other filings with the applicable Canadian securities regulatory authorities or the Securities and Exchange Commission ("SEC"). For a more thorough discussion of the risks associated with our business, see the "Risk Factors" section in our annual report for the year ended December 31, 2009 filed with the SEC on Form 10-K.

Given these uncertainties, assumptions and risk factors, investors are cautioned not to place undue reliance on such forward-looking statements. Except as required by law, we disclaim any obligation to update any such factors or to publicly announce the result of any revisions to any of the forward-looking statements contained in this press release to reflect future results, events or developments.

(C)2010 Angiotech Pharmaceuticals, Inc. All Rights Reserved.

About the Quill(TM) Self-Ret
'/>"/>

SOURCE Angiotech Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
2. Angiotech receives favourable patent decision from New Zealands Intellectual Property Office
3. Angiotech reaches agreement with Johnson & Johnson to settle outstanding patent litigation
4. Angiotech to participate in UBS Global Life Sciences Conference
5. Angiotech announces intent to file 510(k) for its innovative 5-FU Central Venous Catheter (CVC) based on positive results from pivotal trial
6. Angiotech Receives CE Mark Approval of Quill(TM) SRS MONODERM(TM), a New Rapidly Resorbing Suture Product Line
7. Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook
8. Angiotech to participate in Bank of America 2007 Credit Conference
9. Angiotech to participate in RBC 2007 Healthcare Conference
10. Angiotech Submits 510(K) To FDA For Its Innovative 5-FU CVC
11. Athersys and Angiotech announce authorization of Phase I intramyocardial stem cell U.S. clinical trial in acute myocardial infarction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... 06, 2015 Follow us ... of nanomaterial with diameter ranging between 2 to ... global nanophotonics materials market. The unique electroluminescent, photoluminescent, ... to quantum confinement effect render the nanoparticles versatile ... of scientific, technological, and commercial applications. A host ...
(Date:5/6/2015)...   University of Maryland (UM) Ventures and ... of an exclusive option by Biomecite Diagnostics for the ... diagnostics to detect inflammatory bowel diseases (IBD), such as ... Florian Fricke and James White developed ... of Maryland School of Medicine,s Institute for Genome Sciences ...
(Date:5/6/2015)... 2015  Oxis Biotech, Inc. (OXIS), a wholly owned ... today that Cassian Yee , M.D., Professor, Department ... the University of Texas MD Anderson Cancer Center joined ... Department of Immunology, Division of Cancer Medicine, and Director, ... at the University of Texas MD Anderson Cancer Center.  ...
(Date:5/6/2015)... Whitefox ( http://www.whitefox.com ... has signed an agreement with  California ... the delivery of an industrial scale membrane system. The ... water, energy and emissions in the production ... project is fully aligned with ...
Breaking Biology Technology:Expanding Applications & Full-Scale Commercialization to Drive the Global Quantum Dots Market, According to a New Report by Global Industry Analysts, Inc. 2Expanding Applications & Full-Scale Commercialization to Drive the Global Quantum Dots Market, According to a New Report by Global Industry Analysts, Inc. 3Biomecite Diagnostics Signs Option Agreement with UM Baltimore to Develop Tools to Detect Inflammatory Bowel Diseases 2Biomecite Diagnostics Signs Option Agreement with UM Baltimore to Develop Tools to Detect Inflammatory Bowel Diseases 3Oxis Biotech Appoints Cassian Yee, M.D. To Its Scientific Advisory Board 2Oxis Biotech Appoints Cassian Yee, M.D. To Its Scientific Advisory Board 3Whitefox Signs Agreement With Pacific Ethanol Inc. 2
... UPPSALA, Sweden, May 25 Beactica AB, the ... has entered,into an agreement with Cubist Pharmaceuticals, Inc. ... agreement, Beactica will use its Sprint(TM) surface plasmon,resonance ... pathogenic bacteria of interest to Cubist. Financial terms ...
... further promote young researchers in Germany, the Deutsche ... new Research Training Groups. This has just been ... DFG in Bonn. The new Research Training Groups ... doctorates in a structured research and qualification programme ...
... OMAHA, Neb., May 22 Transgenomic, Inc. (OTC Bulletin ... Schuh, Ph.D. and Michael B. McNulty to its Board ... Executive Officer of Sorrento Therapeutics, Inc. (STI). STI ... antibody library construction technology, the STI technology, which applies ...
Cached Biology Technology:DFG establishes 14 new research training groups 2DFG establishes 14 new research training groups 3DFG establishes 14 new research training groups 4DFG establishes 14 new research training groups 5DFG establishes 14 new research training groups 6DFG establishes 14 new research training groups 7Transgenomic, Inc. Announces Appointment of New Board Members 2Transgenomic, Inc. Announces Appointment of New Board Members 3
(Date:3/23/2015)... 23, 2015  In the 2014 fiscal year, irs.gov ... losses. This figure accounts for a fraction of the ... Nilson Report, exceeds $11 billion globally. The polygraph has ... crime has occurred. Investor Mark Saint Juste ... Joe Paolella partnered to administer the test in ...
(Date:3/20/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/4stcg3/india_sensors ) ... Sensors Market Forecast and Opportunities 2020" report ... is projected to grow at a CAGR over ... industrial and healthcare sectors are the key application ... adoption of MEMS technology in sensors is growing ...
(Date:3/20/2015)... March 20, 2015 NXT-ID, Inc. (NASDAQ: ... company focused on the growing mobile commerce market, announces ... one of the products featured in 2015 "I Want ... 11:00 PM EST on the DIY Network.   ... Las Vegas , site of the 2015 International ...
Breaking Biology News(10 mins):Polygraph Test Now Used to Protect Investors From Fraud 2Polygraph Test Now Used to Protect Investors From Fraud 3India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 2India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 3NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 2NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 3
... that bigger, stronger, faster organisms have a distinct advantage ... a given community. But new research from the ... organisms increase their chances of survival if they evolve ... as well, a sort of "survival of the weakest." ...
... premier cancer congress: The 2011 European Multidisciplinary Cancer ... 2011 European Multidisciplinary Cancer Congress will take place ... ( www.stofair.se ) from Friday 23 September to ... build on the success of the previous ECCO ...
... a collection of test tubes in her Iowa State University ... were holding very weak coffee. That meant microorganisms in ... sugars into hydrocarbons, said Jarboe, an Iowa State assistant professor ... sugars in those test tubes were produced by the fast ...
Cached Biology News:Bacteria develop restraint for survival in a rock-paper-scissors community 2European Multidisciplinary Cancer Congress 2011 2Iowa State hybrid lab combines technologies to make biorenewable fuels and products 2Iowa State hybrid lab combines technologies to make biorenewable fuels and products 3
... Cleaves a-(1-3)- and a(1-6)-linked, ... glycoproteins. It is particularly efficient for removing ... must be neutral or above, for example, ... Definition: One unit will hydrolyze 1 ...
... antibody is specific for human cardiac troponin subunit ... Ca-binding signals responsible for contraction of cardiac muscle. ... complex in human cells. It also cross-reacts with ... Antigen: Highly purified human cardiac ...
cystatin A (N-18)...
... is pleased to offer the ATTO-TAG ... detection of primary amines. Developed by ... the ATTO-TAG reagents are similar to ... (NDA) and anthracene-2,3-dicarboxaldehyde, all of which ...
Biology Products: